Significance of Prior Digestive Colonization with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Patients with Ventilator-Associated Pneumonia

Critical Care Medicine

Volumn 44, Issue 4, 2016, Pages 699-706

  Bruyère, Rémi ^a   Vigneron, Clara ^a   Bador, Julien ^b   Aho, Serge ^a   Toitot, Amaury ^a   Quenot, Jean Pierre ^a   Prin, Sébastien ^a   Charles, Pierre Emmanuel ^a  

^a HÔPITAL DU BOCAGE   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

enterobacteriacae; extended spectrum lactamase; multidrug resistance; ventilator associated pneumonia

Indexed keywords

CARBAPENEM DERIVATIVE; BETA LACTAMASE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATION; COHORT ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MECHANICAL VENTILATOR; MIDDLE AGED; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VENTILATOR ASSOCIATED PNEUMONIA; AGED; BIOSYNTHESIS; DIAGNOSIS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; FECES; GENETICS; HETEROZYGOTE; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MULTIDRUG RESISTANCE; TRANSMISSION;

AGED; BETA-LACTAMASES; CARRIER STATE; DRUG RESISTANCE, MULTIPLE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FECES; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84947093034     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001471     Document Type: Article

References (33)

1. Tedja R, Nowacki A, Fraser T, The impact of multidrug resistance on outcomes in ventilator-associated pneumonia. Am J Infect Control 2014 42 542 545
2. Iregui M, Ward S, Sherman G, Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002 122 262 268
3. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005 171 388 416
4. Donaldson AD, Razak L, Liang LJ, Carbapenems and subsequent multiresistant bloodstream infection: Does treatment duration matter? Int J Antimicrob Agents 2009 34 246 251
5. Cantón R, Novais A, Valverde A, Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008 14 144 153
6. Ben-Ami R, Rodríguez-Baño J, Arslan H, A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 2009 49 682 690
7. Rodríguez-Baño J, Picón E, Gijón P, Spanish Network for Research in Infectious Diseases (REIPI) Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: Risk factors and prognosis. Clin Infect Dis 2010 50 40 48
8. Saurina G, Quale JM, Manikal VM, Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: Epidemiology and relation to antibiotic usage patterns. J Antimicrob Chemother 2000 45 895 898
9. de Kraker ME, Wolkewitz M, Davey PG, BURDEN Study Group Clinical impact of antimicrobial resistance in European hospitals: Excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother 2011 55 1598 1605
10. Razazi K, Derde LP, Verachten M, Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit. Intensive Care Med 2012 38 1769 1778
11. Pitout JD, Nordmann P, Laupland KB, Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005 56 52 59
12. Cassier P, Lallechère S, Aho S, Cephalosporin and fluoroquinolone combinations are highly associated with CTX-M β-lactamase-producing Escherichia coli: A case-control study in a French teaching hospital. Clin Microbiol Infect 2011 17 1746 1751
13. Crouch TW, Higuchi JH, Coalson JJ, Pathogenesis and prevention of nosocomial pneumonia in a nonhuman primate model of acute respiratory failure. Am Rev Respir Dis 1984 130 502 504
14. Bhalla A, Pultz NJ, Ray AJ, Antianaerobic antibiotic therapy promotes overgrowth of antibiotic-resistant, gram-negative bacilli and vancomycin-resistant enterococci in the stool of colonized patients. Infect Control Hosp Epidemiol 2003 24 644 649
15. Hamet M, Pavon A, Dalle F, Candida spp. airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia. Intensive Care Med 2012 38 1272 1279
16. Bruyere R, Vigneron C, Prin S, Impact of prior statin therapy on the outcome of patients with suspected ventilator-associated pneumonia: An observational study. Crit Care 2014 18 R83
17. Singh N, Rogers P, Atwood CW, Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000 162 505 511
18. Fartoukh M, Maitre B, Honoré S, Diagnosing pneumonia during mechanical ventilation: The clinical pulmonary infection score revisited. Am J Respir Crit Care Med 2003 168 173 179
19. Jarlier V, Nicolas MH, Fournier G, Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev Infect Dis 1988 10 867 878
20. Fàbregas N, Torres A, El-Ebiary M, Histopathologic and microbiologic aspects of ventilator-associated pneumonia. Anesthesiology 1996 84 760 771
21. Kett DH, Cano E, Quartin AA, Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: An observational, multicentre cohort study. Lancet Infect Dis 2011 11 181 189
22. Harris AD, McGregor JC, Johnson JA, Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis 2007 13 1144 1149
23. Friedmann R, Raveh D, Zartzer E, Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing Enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol 2009 30 534 542
24. Chan JD, Dellit TH, Choudhuri JA, Active surveillance cultures of methicillin-resistant Staphylococcus aureus as a tool to predict methicillin-resistant S. aureus ventilator-associated pneumonia. Crit Care Med 2012 40 1437 1442
25. Sarikonda KV, Micek ST, Doherty JA, Methicillin-resistant Staphylococcus aureus nasal colonization is a poor predictor of intensive care unit-acquired methicillin-resistant Staphylococcus aureus infections requiring antibiotic treatment. Crit Care Med 2010 38 1991 1995
26. Blot S, Depuydt P, Vogelaers D, Maximizing rates of empiric appropriate antibiotic therapy with minimized use of broad-spectrum agents: Are surveillance cultures the key? Intensive Care Med 2008 34 2130 2133
27. Depuydt P, Benoit D, Vogelaers D, Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia. Intensive Care Med 2008 34 675 682
28. Michel F, Franceschini B, Berger P, Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: A role for routine endotracheal aspirate cultures. Chest 2005 127 589 597
29. Papadomichelakis E, Kontopidou F, Antoniadou A, Screening for resistant gram-negative microorganisms to guide empiric therapy of subsequent infection. Intensive Care Med 2008 34 2169 2175
30. Pirracchio R, Mateo J, Raskine L, Can bacteriological upper airway samples obtained at intensive care unit admission guide empiric antibiotherapy for ventilator-associated pneumonia? Crit Care Med 2009 37 2559 2563
31. Safdar N, Crnich CJ, Maki DG, The pathogenesis of ventilator-associated pneumonia: Its relevance to developing effective strategies for prevention. Respir Care 2005 50 725 739
32. Torres A, El-Ebiary M, Soler N, Stomach as a source of colonization of the respiratory tract during mechanical ventilation: Association with ventilator-associated pneumonia. Eur Respir J 1996 9 1729 1735
33. Piroth L, Aubé H, Doise JM, Spread of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: Are beta-lactamase inhibitors of therapeutic value? Clin Infect Dis 1998 27 76 80